The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte MURALEEDHARAN G. NAIR and
BOLLEDDULA JAYAPRAKASAM
__________
Appeal No. 2006-1245
Application No. 10/294,106
__________
ON BRIEF
__________
Before SCHEINER, GRIMES, and GREEN, Administrative Patent Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This appeal involves claims to selectively inhibiting the COX-2 enzyme. The
examiner has rejected the claims as indefinite and anticipated. We have jurisdiction
under 35 U.S.C. § 134. We conclude that the claims are definite. However, we agree
with the examiner that the claims are anticipated, although for reasons different from
those advanced by the examiner. We therefore vacate the rejections based on the prior
art and enter new grounds of rejection.
Background
“Cyclooxygenase-1 (COX-1) and -2 (COX-2) enzymes are responsible for the
conversion of arachidonic acid, a lipid present in the cell, to prostaglandins.
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007